Spotlight Therapeutics Raises $36.5 Million Series B to Advance a Pipeline of Cell-Targeted In Vivo CRISPR Gene Editing Biologics
https://www.businesswire.com/news/home/20220322005265/en/Spotlight-Therapeutics-Raises-36.5-Million-Series-B-to-Advance-a-Pipeline-of-Cell-Targeted-In-Vivo-CRISPR-Gene-Editing-Biologics
© 2022 Regents of the University of California. All Rights Reserved.